The 20 Best Familial Prostate Cancer Doctors Near Me in Greenvale, NY

Gary Goldberg is a Urologist practicing medicine in Manhasset, New York. Dr. Goldberg is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Ureteroscopy, and Reconstructive Urology Surgery. Dr. Goldberg is board certified in American Board Of Urology.

Elliot Paul is a Urologist practicing medicine in New Hyde Park, New York. Dr. Paul is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Enlarged Prostate (BPH), Perirenal Abscess, Ureteroscopy, and Prostatectomy. Dr. Paul is board certified in American Board Of Urology.

Mykola Alyskewycz is a Urologist practicing medicine in Glen Cove, New York. Dr. Alyskewycz is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Ureteroscopy, and Prostatectomy.

As Senior Vice President of the Urology Service Line, Chair of theSmith Institute for Urology, and Chair of Urology at the Zucker Schoolof Medicine at Hofstra/Northwell, Samir Taneja, MD will establish hisclinical practice at Lenox Hill Hospital and Long Island Jewish MedicalCenter focused on the surgical management of prostate cancerand renal tumors. He is an expert in urologic oncology, renowned fortransforming the field of prostate cancer diagnosis and treatmentby improving methods of prostate imaging, cancer detection, anddisease localization. Having performed thousands of robotic, ablative,laparoscopic and open surgical procedures, his specific clinical focushas been in improving prostate cancer patient outcomes throughpioneering techniques for focal ablative therapy, refining surgicaltechniques for robotic prostatectomy and partial nephrectomy,devising accelerated recovery pathways for robotic prostatectomy/partial nephrectomy, and providing muti-modal surgical approachesfor patients with high risk and recurrent prostate cancer. As leader ofthe department, he will strive to ensure individualized care of urologicdisease through state-of-the-art surgical approaches and multi-disciplinary care.Prior to joining Northwell, Dr Taneja was a faculty member of NYUGrossman School of Medicine for 29-years as a tenured professorof urology, radiology, and biomedical engineering. Most recently heserved as Director of the Division of Urologic Oncology and ViceChair in the Department of Urology at NYU Langone Health, as well asGenitourinary Program Leader in the Perlmutter Cancer Center.Dr. Taneja has conducted extensive clinical research on the use ofimaging in prostate cancer and is considered a pioneer in the use ofMRI to diagnose and localize prostate cancer and the emerging field ofprostate cancer focal therapy. He has authored more than 250 articles,30 book chapters, and six textbooks and monographs on urologiccancer and surgery. He is the editor of Taneja's Complications ofUrologic Surgery: Prevention and Diagnosis, one of the most widely readtextbooks in American Urology. Dr. Taneja is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Taneja is board certified in American Board Of Urology.

Joph Steckel is a Urologist practicing medicine in Lake Success, New York. Dr. Steckel is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Steckel is board certified in American Board Of Urology.

Sang Sim is an Internal Medicine specialist and a Radiation Oncologist practicing medicine in New Hyde Park, New York. Dr. Sim is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Laryngeal Cancer, and Endometrial Cancer.

Michael J. Schwartz, MD, is Chief of Urology at Long Island Jewish Medical Center and Director of Urology Services for Northwell Health's Central Region. Dr. Schwartz specializes in minimally invasive procedures to treat prostate cancer. He has vast experience in robotic-assisted radical prostatectomy, evolving surgical techniques over time to minimize treatment-related side effects. For qualifying prostate cancer patients, Dr. Schwartz also offers focal ablation therapies, using sophisticated image guidance and focal tissue ablation to eradicate prostate cancer with few side effects. He has additional expertise in urologic oncology and surgery to treat kidney, bladder, adrenal and testicular cancers. Becoming a doctor always felt natural to me, Dr. Schwartz says. I was always interested in helping others, and urology is a wonderful blend of both medical and surgical care, allowing for the development of long-term relationships with my patients. Dr. Schwartz earned his medical degree from Warren Alpert Medical School of Brown University and pursued his residency training in urology at New York-Presbyterian Hospital, Cornell. He received his fellowship training in advanced laparoscopic and endoscopic surgery at North Shore University Hospital and Long Island Jewish Medical Center. Dr. Schwartz values a team-based approach to care, working with radiologists, pathologists and medical oncologists to create individualized, evidence-based treatment plans. He also carefully listens to patients to meet their unique goals and preferences. In addition to treating prostate cancer, Dr. Schwartz is a pioneer in prostate cancer diagnosis. He was an early adopter of transperineal biopsy-which eliminates the infection risk associated with the prior transrectal method-and helped the Smith Institute of Urology transition to using that approach for all patients requiring prostate biopsy across Northwell Health. His research focuses on both diagnostics and treatment of prostate cancer, and he is involved with several clinical trials for focal therapy. He is a member of the American Urological Association and Society of Urologic Oncology. He is Associate Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. For Dr. Schwartz, one of the best parts of his job is getting to know his patients. I have the privilege of seeing their humanity, learning about their lives and discovering what's important to them, he says. Their experiences inspire me every day. Dr. Schwartz is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Enlarged Prostate (BPH), Reconstructive Urology Surgery, and Nephrectomy. Dr. Schwartz is board certified in American Board Of Urology.

"Xinhua Zhu, MD, PhD, is a medical oncologist and hematologist at Monter Cancer Center, where he specializes in treating genitourinary cancer, including cancer of the prostate, kidney, bladder and testicles. He focuses on compassionate, evidence-based care, rooted in his research background.""My research helps me think outside the box when creating treatment plans,"" says Dr. Zhu, ""and enables me to explain to patients the mechanisms behind the treatments I'm using."" His research interests include finding new treatment targets for generating hormone resistance in prostate cancer and metastatic castration-resistant prostate cancer, exploring biomarkers in bladder cancer to guide decisions about chemotherapy, exploring the mechanisms for kidney cancer metastasis, and investigating the effectiveness of immunotherapy for genitourinary cancers.Dr. Zhu earned his medical degree at Suzhou Medical College and practiced internal medicine in China. He obtained his PhD in cancer study at Shanghai Jiao Tong University School of Medicine, then moved to the United States for postdoctoral research training at Memorial Sloan Kettering Cancer Center, an internal medicine residency at Mount Sinai School of Medicine. He attended NYU School of Medicine for fellowship training in hematology and medical oncology.In 2013, he joined Northwell Health, where he regularly meets with a multidisciplinary group of pathologists, radiologists, radiation oncologists, surgical oncologists, geneticists and the Molecular Tumor Board to create treatment plans.As an associate professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he twice received the Medical Oncology/Hematology Fellowship Program Teacher of the Year Award. Dr. Zhu is also a phase 1 cancer research program director at Monter Cancer Center. He is assistant investigator at the Feinstein Institutes for Medical Research, and a member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the Principal Investigator for the Northwell Health NCI Community Oncology Research Program (NCORP)For Dr. Zhu, being able to pursue both scientific investigation and patient care is the best part of his work. ""I can take research from the bench to the bedside, providing people with the best possible treatments,"" he says.". Dr. Zhu is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, and Clear Cell Sarcoma. Dr. Zhu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Dr. Rofeim joined the medical staff of the Smith Institute for Urology and the Hofstra NS-LIJ School of Medicine in July 2012 after being in private practice in the New York area for 10 years. After completion of general surgery training at LIJ and Beth Israel Medical Centers, he continued with urology residency at LIJ Medical Center where he served as the chief resident under the mentorship of Drs. Arthur Smith and Gopal Badlani. He graduated magna cum laude from CUNY-Queens College and cum laude from SUNY-Downstate Medical Center.During his undergraduate training, he won numerous awards including the Donald E. Lancefield Prize, the Howard Hughes Summer Fellowship Award for undergraduate research, the Robert Keating Memorial Award and was included in the National Dean's List. He received the prestigious American Medical Association Physician Recognition Award and AUA/Praecis Gerald P. Murphy Scholar Award for Distinction in the study of prostate cancer. During his residency training, he won the Academic Annual Research Competition at LIJ Medical Center.He is a member of the Alpha Omega Alpha Medical Honor Society where he served as the vice president, the American Urologic Society and the New York Section of the American Urologic Society. Dr. Rofeim is a diplomate of the American Board of Urology (Board certified) and a fellow of the American College of Surgeons. He has published several articles and a book chapter in the fileds of fertility and incontinence and has presented numerous abstracts at the American Urologic Association annual meetings and other prestigious societies in topics of fertility and interstitial cystitis. Interests include:Enlarged ProstateErectile DysfunctionGeneral UrologyIncontinenceKidney StonesUrologic Cancers. Dr. Rofeim is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Diphallia, Enlarged Prostate (BPH), and Ureteroscopy. Dr. Rofeim is board certified in American Board Of Urology.

Mary O'keeffe is a Hematologist and an Oncologist practicing medicine in Mineola, New York. Dr. O'keeffe is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Urothelial Cancer, Familial Prostate Cancer, Bone Marrow Aspiration, and Endoscopy.

Dimitri Kessaris is a Urologist practicing medicine in Manhasset, New York. Dr. Kessaris is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), and Urinary Incontinence.

Michael Ohebshalom is a Urologist practicing medicine in Manhasset, New York. Dr. Ohebshalom is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Premature Ejaculation, Enlarged Prostate (BPH), Varicocele, and Urinary Tract Infection in Children.

Shawn Zimberg is a Radiation Oncologist practicing medicine in New Hyde Park, New York. Dr. Zimberg is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Anal Cancer.

Jeffrey Lumerman is a Urologist practicing medicine in New Hyde Park, New York. Dr. Lumerman is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Prostate Cancer, Perirenal Abscess, Carbuncle, and Ureteroscopy.

Todd Carpenter is a Radiation Oncologist practicing medicine in Mineola, New York. Dr. Carpenter is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Prostate Cancer, and Small Cell Lung Cancer (SCLC).

Michael J. Drabkin, MD is the Chief of Interventional Radiology at NY Imaging / New York Cancer & Blood Specialists (NYCBS), serving Long Island and the greater New York City area. He is board-certified in both Diagnostic Radiology and Interventional Radiology.His practice focuses on minimally invasive, same-day treatments for enlarged prostate (BPH), uterine fibroids, varicoceles, and cancer. Dr. Drabkin performs more than 650 Prostate Artery Embolizations (PAE) per year, placing him among the highest-volume PAE physicians in the United States. He has performed over 20,000 image-guided procedures during his career.He completed his fellowship in Vascular and Interventional Radiology at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, where he served as Chief Fellow. He earned his undergraduate degree at Columbia University and his medical degree from SUNY Upstate Medical University.Dr. Drabkin is a Castle Connolly Top Doctor, and an active member of the Society of Interventional Radiology and the American Urological Association. He is well published in professional journals, and has been an invited speaker at national and international conferences. Dr. Drabkin is rated as an Experienced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Ascites, Familial Colorectal Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Liver Embolization. Dr. Drabkin is board certified in Interventional Radiology and Diagnostic Radiology. Dr. Drabkin is currently accepting new patients.

Francisco Garcia is a Hematologist and an Oncologist practicing medicine in New Hyde Park, New York. Dr. Garcia is rated as an Experienced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Alpha Thalassemia, Alpha Thalassemia X-Linked Intellectual Disability Syndrome, Thalassemia, and Iron Deficiency Anemia.

Michael Levine is a Urologist practicing medicine in New Hyde Park, New York. Dr. Levine is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Perirenal Abscess, and Ureteroscopy.

Randy Makovsky is a Urologist practicing medicine in New Hyde Park, New York. Dr. Makovsky is rated as an Experienced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Bladder Stones, Urinary Tract Infection in Children, and Urinary Tract Infection (UTI).

Kai Tsao, MD, MS, is the system chief of solid tumor oncology, medical director of the R.J. Zuckerberg Cancer Center, and medical director of the medical oncology prostate cancer program at the Northwell Cancer Institute. He specializes in cancers of the genitourinary organs and has more than a decade of clinical experience. His research focuses on the development of biomarkers and novel therapies for patients with genitourinary cancers.Dr. Tsao was inspired to become an oncologist after witnessing many close family and friends suffering from cancer. He completed medical school training at SUNY Downstate, an internal medicine residency at Long Island Jewish Medical Center, and a fellowship in hematology and medical oncology at Mount Sinai Hospital. He earned a master's degree in healthcare delivery leadership at Icahn School of Medicine at Mount Sinai and completed Lean Six Sigma training at Johns Hopkins.Prior to joining Northwell, Dr. Tsao served as medical director of the Ruttenberg Treatment Center, medical director of the medical oncology prostate cancer program, and physician leader for internal oncology collaborations at the Mount Sinai Hospital, Tisch Cancer Institute. In these roles, Dr. Tsao and his team built a cancer center that is patient centered, quality driven, scientifically innovative, and provided multi-disciplinary care to patients with cancer.For me, patient care much more than the cancer diagnosis and treatment. It is essential to address the many needs of our cancer patients: emotional well-being, social support, nutrition, physical activity, financial challenges and more. We aim to provide the best support for our patients, one at a time.Dr. Tsao is an accomplished physician-scientist who has authored more than 80 peer-reviewed publications in the field of genitourinary oncology. He serves as associate editor of Genitourinary Oncology, Frontiers in Oncology. His leadership in carrying out complex clinical trials in targeted therapies and immunotherapies positions his patients at the forefront of cutting-edge cancer research and patient-centered care.What I most enjoy every day is seeing patients under our care, despite the devastation of their cancer diagnosis, beating their cancer and living a life that was not considered a possibility years ago. Our mission at Northwell Cancer Institute is to make this a reality for every single patient. Dr. Tsao is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Orchiectomy, and Nephrectomy. Dr. Tsao is board certified in American Board Of Internal Medicine/Medical Oncology.